These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 644552)

  • 1. Effect of dipyridamole on platelet aggregation in cerebral microcirculation of the mouse.
    Rosenblum WI; El-Sabban F
    Thromb Res; 1978 Jan; 12(1):181-5. PubMed ID: 644552
    [No Abstract]   [Full Text] [Related]  

  • 2. Antioxidants alleviate nicotine-induced platelet aggregation in cerebral arterioles of mice in vivo.
    Fahim MA; Nemmar A; Singh S; Hassan MY
    Physiol Res; 2011; 60(4):695-700. PubMed ID: 21574756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of platelet aggregation in whole blood by dipyridamole and aspirin.
    Heptinstall S; Fox S; Crawford J; Hawkins M
    Thromb Res; 1986 Apr; 42(2):215-23. PubMed ID: 3715801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect on various platelet parameters of dipyridamole (225 mg/day) acetylsalicylic acid (150 mg/day) and their combination in healthy volunteers].
    Aguilar Muñoz A; de la Cruz Cortés JP; Martos Crespo F; de Pablo Molina J; Sánchez de la Cuesta F
    Med Clin (Barc); 1985 Nov; 85(18):743-5. PubMed ID: 4094486
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of dipyridamole and low-dose aspirin therapy on platelet adhesion to vascular subendothelium.
    Lauri D; Zanetti A; Dejana E; de Gaetano G
    Am J Cardiol; 1986 Dec; 58(13):1261-4. PubMed ID: 3788816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dipyridamole potentiates the inhibition of platelet aggregation by aspirin (in human platelet rich plasma and whole blood).
    Violi F; Praticò D; Iuliano L; Balsano F
    J Lipid Mediat; 1991; 4(1):61-7. PubMed ID: 1909906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of low doses of aspirin and dipyridamole on platelet aggregation in the dog coronary artery.
    Weselcouch EO; Humphrey WR; Aiken JW
    J Pharmacol Exp Ther; 1987 Jan; 240(1):37-43. PubMed ID: 3543298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of therapy on platelet activating factor-induced aggregation in acute stroke.
    Joseph R; Welch KM; D'Andrea G
    Stroke; 1989 May; 20(5):609-11. PubMed ID: 2718200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of combined treatment with aspirin and dipyridamole on oxidative homeostasis in mouse serum.
    Ivasenko IN; Dorofeikov VV; Shlyakhto EV
    Bull Exp Biol Med; 2005 Jul; 140(1):22-4. PubMed ID: 16254611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dipyridamole alone and in combination with aspirin on whole blood platelet aggregation, PGI2 generation, and red cell deformability ex vivo in man.
    Saniabadi AR; Fisher TC; McLaren M; Belch JF; Forbes CD
    Cardiovasc Res; 1991 Mar; 25(3):177-83. PubMed ID: 2029709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin and dipyridamole inhibition of collagen-induced platelet aggregation and release in cynomolgus monkeys.
    Wang ZG; McCann RL; Hagen PO
    Chin Med J (Engl); 1984 Jan; 97(1):19-23. PubMed ID: 6428828
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of platelet aggregation and adherence to prosthetic vascular grafts by aspirin and dipyridamole.
    Oblath RW; Buckley FO; Green RM; Schwartz SI; DeWeese JA
    Surgery; 1978 Jul; 84(1):37-44. PubMed ID: 149385
    [No Abstract]   [Full Text] [Related]  

  • 13. [Inhibition of collagen-induced platelet aggregation and release function by aspirin and dipyridamole in cynomolgus monkey].
    Wang ZG
    Zhonghua Xin Xue Guan Bing Za Zhi; 1984 Jun; 12(2):131-3. PubMed ID: 6489139
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of the effects of aspirin and dipyridamole on platelet aggregation in vivo and ex vivo.
    Buchanan MR; Hirsh J
    Thromb Res; 1978 Sep; 13(3):517-29. PubMed ID: 741444
    [No Abstract]   [Full Text] [Related]  

  • 15. Dipyridamole and aspirin in relation to platelet aggregation and vessel wall prostaglandin generation.
    Mehta J; Mehta P
    J Cardiovasc Pharmacol; 1982; 4(4):688-93. PubMed ID: 6181345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining antiplatelet agents: potentiation between aspirin and dipyridamole.
    Gresele P; Armout J; Deckmyn H; Vermylen J
    Lancet; 1985 Apr; 1(8434):937-8. PubMed ID: 2858787
    [No Abstract]   [Full Text] [Related]  

  • 17. Platelet aggregation in the cerebral microcirculation: effect of aspirin and other agents.
    Rosenblum WI; El-Sabban F
    Circ Res; 1977 Mar; 40(3):320-8. PubMed ID: 13943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of aspirin and dipyridamole and its derivatives on platelet disaggregation.
    Morris CD; Heslop PA
    Cent Afr J Med; 1977 Nov; 23(11):251-3. PubMed ID: 603896
    [No Abstract]   [Full Text] [Related]  

  • 19. Platelet deposition on human atherosclerotic lesions is decreased by low-dose aspirin in combination with dipyridamole.
    Sinzinger H; O'Grady J; Fitscha P
    J Int Med Res; 1988; 16(1):39-43. PubMed ID: 3350203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet aggregation and vasoconstriction in undamaged microvessels on cerebral surface adjacent to brain traumatized by a penetrating needle.
    Rosenblum WI; El-Sabban F
    Microvasc Res; 1978 May; 15(3):299-307. PubMed ID: 692444
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.